lentivirus-efnb2 cdnas (Shanghai GenePharma)
Structured Review

Lentivirus Efnb2 Cdnas, supplied by Shanghai GenePharma, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cdnas/lentivirus+efnb2+cdnas/pmc09816060-285-2-7
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "Adaptive activation of EFNB2/EPHB4 axis promotes post-metastatic growth of colorectal cancer liver metastases by LDLR-mediated cholesterol uptake"
Article Title: Adaptive activation of EFNB2/EPHB4 axis promotes post-metastatic growth of colorectal cancer liver metastases by LDLR-mediated cholesterol uptake
Journal: Oncogene
doi: 10.1038/s41388-022-02519-z
Figure Legend Snippet: A Upregulated genes identified were GSE49355, GSE6988, and GSE35834 (CRC LM), and GSE41258 and GSE41568 (CRC PM). B KEGG pathway analysis of upregulated genes in CRC LM. C mRNA expression of EFNB2 in NC, CRC, and LM samples in GSE49355, GSE6988, and GSE35834. D mRNA expression of EFNB2 in CRC and PM samples in GSE41568. E mRNA expression of EFNB2 in CRC and PM samples in GSE41258. F Protein expression of EFNB2 in matched NC, CRC, LM tissues ( n = 15 per group), Scale bar: 50 μm. G mRNA and protein expression of EFNB2 in NCM460 and six CRC cell lines. H Orthotopic tumor models, a liver metastasis model by spleen injection and a lung metastasis model by tail vein injection, were established by injecting SW480 cells into null mice. I mRNA and protein expression of EFNB2 in orthotopic tumor tissue at different time points (1 week, 2 weeks, and 3 weeks) ( n = 6). J mRNA and protein expression of EFNB2 in lung metastasis tumor tissue at different time points (1 week, 2 weeks, and 3 weeks) ( n = 6). K mRNA and protein expression of EFNB2 in liver metastasis tumor tissue at different time points (1 week, 2 weeks, and 3 weeks) ( n = 6). L Imaging of animal model of liver metastasis by spleen injection with sh-EFNB2 or sh-NC SW620 Luc cells ( n = 6). Scale color bar: 9.74 × 10 7 –4.19 × 10 8 . M Imaging of animal intrahepatic model by liver injection with sh-EFNB2 or sh-NC SW620 Luc cells ( n = 5 per group). Scale color bar: 3.75 × 10 6 –4.36 × 10 7 . N LM tumor tissues from sh-EFNB2 or sh-NC mice were digested and LM cells were cultured. O The viability of SW620 cells from LM tumor tissues in sh-EFNB2 and sh-NC groups, as analyzed using CCK-8 assays. P Proliferation of SW620 cells from LM tumor tissues in sh-EFNB2 and sh-NC groups, as analyzed using EdU assays. Scale bar: 50 μm. All experiments were performed in triplicate. Measurement data were presented as the mean ± SD. Student’s t -tests were used for statistical analysis. ns. represents no statistical difference; * p < 0.05; *** p < 0.001.
Techniques Used: Expressing, Injection, Imaging, Animal Model, Cell Culture, CCK-8 Assay
Figure Legend Snippet: A Schematic diagram of signal conduction direction. B Protein structure of EFNB2. C Construction of four types of EFNB2 overexpression plasmids, including EFNB2 full length (FL), EFNB2 ΔC, EFNB2 ΔC + H, and EFNB2 Δ E . D Liver metastasis model by spleen injection with vector, EFNB2 FL, EFNB2 ΔC, EFNB2 ΔC + H, and EFNB2 Δ E SW480 Luc cells ( n = 6 per group) and animal imaging to monitor tumor growth and staining PCNA in LM tumor tissues (Purple: PCNA, Blue: DAPI). Scale bar: 25 μm. E Viability of SW480 and HT29 cells transfected with vector, EFNB2 FL, EFNB2 ΔC, EFNB2 ΔC + H, and EFNB2 ΔE, as analyzed using CCK-8 assays. F Viability of SW480 and HT29 cells transfected with vector, EFNB2 ΔE, Vector + rEFNB2 ΔC + H, and EFNB2 ΔE + rEFNB2 ΔC + H, as analyzed using CCK-8 assays. G EdU assays of SW480 and HT29 cells transfected with vector, EFNB2 FL, EFNB2 ΔC, EFNB2 ΔC + H, and EFNB2 ΔE. H EdU assays of SW480 and HT29 cells transfected with vector, EFNB2 ΔE, Vector + rEFNB2 ΔC + H, and EFNB2 ΔE + rEFNB2 ΔC + H. Scale bar: 25 μm. All experiments were performed in triplicate. Measurement data are presented as the mean ± SD. Student’s t -tests were used for statistical analysis. ns. represents no statistical difference; * p < 0.05; *** p < 0.001.
Techniques Used: Over Expression, Injection, Plasmid Preparation, Imaging, Staining, Transfection, CCK-8 Assay
Figure Legend Snippet: A mRNA expression of EPHB4 and other EPHs in CRC and LM samples in GSE6988. B Viability of SW480 and HT29 cells transfected with vector, EFNB2-OE, and EFNB2-OE + siEPHB4, as analyzed using CCK-8 assays. C EdU assays of SW480 and HT29 cells transfected with vector, EFNB2-OE, EFNB2-OE + siEPHB4, and EFNB2-OE + NVP-BHG712. Scale bar: 25 μm. D Liver metastasis model created by spleen injection with SW480 luc cells transfected with vector, EFNB2-OE, EFNB2-OE + siEPHB4, and EFNB2-OE + NVP-BHG712 ( n = 6 per group), and animal imaging to monitor tumor growth. Scale color bar: 2.81 × 10 6 –4.40 × 10 7 . E Liver infection model with SW480 luc cells transfected with vector, EFNB2-OE, EFNB2-OE + siEPHB4, and EFNB2-OE + NVP-BHG712 ( n = 6 per group), and animal imaging to monitor tumor growth. Scale color bar: 2.50 × 10 7 –4.55 × 10 8 . F PCNA staining by IHC in LM tumor tissues (vector, EFNB2-OE, EFNB2-OE + siEPHB4, and EFNB2-OE + NVP-BHG712). Scale bar: 50 μm. G PCNA staining by IHC in tumor tissues (vector, EFNB2-OE, EFNB2-OE + siEPHB4, and EFNB2-OE + NVP-BHG712). Scale bar: 50 μm. H LM tumor tissues from vector or EFNB2-OE mice were digested and LM cells were cultured. I The viability of SW480 cells from LM tumor tissues in the vector and EFNB2-OE groups, as analyzed using CCK-8 assays. J The proliferation of SW480 cells from LM tumor tissues in the vector and EFNB2-OE groups, as analyzed using EdU assays. Scale bar: 50 μm. All experiments were performed in triplicate. Measurement data are presented as the mean ± SD. Student’s t -tests were used for statistical analysis. ns. represents no statistical difference; * p < 0.05; ** p < 0.01; *** p < 0.001.
Techniques Used: Expressing, Transfection, Plasmid Preparation, CCK-8 Assay, Injection, Imaging, Infection, Staining, Cell Culture
Figure Legend Snippet: A GSEA analysis of EFNB2 expression in CRC, as evaluated using GSE6988. A total of 24 CRC LM samples were divided into two groups, including a high EFNB2 expression group (12 samples) and a low EFNB2 expression group (12 samples). B Total cholesterol levels were measured in the CRC LM tumor tissues, including the vector, EFNB2-OE, EFNB2-OE + siEPHB4, and EFNB2-OE + NVP-BHG712 groups ( n = 6 per group). C Total cholesterol levels in the tumor tissues of the liver injection model, including the vector, EFNB2-OE, EFNB2-OE + siEPHB4, and EFNB2-OE + NVP-BHG712 groups ( n = 6 per group). D Cholesterol levels were measured in CRC cells. E Cholesterol levels were measured in SW480 and HT29 cells, including the vector, EFNB2-OE and EFNB2-OE + siEPHB4, EFNB2-OE + NVP-BHG712 groups, with or without 10% FBS treatment. F Expression of cholesterol uptake related genes (LDLR, VLDLR, and SCARB1), and cholesterol synthesis related genes (HMGCS1, HMGCR, NSDHL, MSMO1, and DHCR24) in CRC LM tumor tissues, including the vector, EFNB2-OE, EFNB2-OE + siEPHB4, and EFNB2-OE + NVP-BHG712 groups ( n = 6 per group). G Expression of cholesterol uptake related genes (LDLR, VLDLR, and SCARB1), and cholesterol synthesis related genes (HMGCS1, HMGCR, NSDHL, MSMO1, and DHCR24) in SW480 cells in FBS-free culture, including the vector, EFNB2-OE, EFNB2-OE + siEPHB4, and EFNB2-OE + NVP-BHG712 groups. H Total cholesterol levels in SW620 and LoVo cells in FBS-free culture, including sh-NC, sh-EFNB2, sh-NC + 5 μg/ml cholesterol (Cho), and sh-EFNB2 + 5 μg/ml Cho. I Total cholesterol levels in SW480 and HT29 cells in FBS-free culture, including vector + 5 μg/ml Cho, EFNB2-OE + 5 μg/ml Cho, and EFNB2-OE + 5 μg/ml Cho + NVP-BHG712. All experiments were performed in triplicate. Measurement data are presented as the mean ± SD. Student’s t -tests were used for statistical analysis. ns. indicated no statistical difference; *** p < 0.001.
Techniques Used: Expressing, Plasmid Preparation, Injection
Figure Legend Snippet: A Protein expression of total SREBP2 and activated SREBP2 in CRC LM tissues transfected with vector and EFNB2-OE ( n = 6). B Transcription factor analysis of LDLR. C STAT3 binding to the promoter region of LDLR in SW480 and SW620 cells, as assessed using ChIP assay. D Role of STAT3 in promoting LDLR transcription, according to a dual luciferase report assay. E Protein expression of LDLR, STAT3, and p-STAT3 in SW620 and LoVo cells, including si-NC, siSTAT3, and SH-4-54 groups. F Protein expression of JAK2, p-JAK2, STAT3, and p-STAT3 in SW480 and HT29 cells, including the vector, EFNB2-OE, EFNB2-OE + NVP-BHG712, and EFNB2-OE + siEPHB4 groups. G Protein expression of JAK2, p-JAK2, STAT3, and p-STAT3 in SW620 and LoVo cells, including the sh-NC, sh-EFNB2, and sh-EFNB2 + rEFNB2 groups. H mRNA and protein expression of LDLR, VLDLR, and SCARB1 in SW480 and HT29 cells, including the vector, EFNB2-OE, EFNB2-OE + SH-4-54, and EFNB2-OE + siSTAT3 groups. All experiments were performed in triplicate. Measurement data are presented as the mean ± SD. Student’s t -tests were used for statistical analysis. ns. indicates no statistical difference; *** p < 0.001.
Techniques Used: Expressing, Transfection, Plasmid Preparation, Binding Assay, Luciferase
Figure Legend Snippet: A LM model created by spleen injection with SW480 luc cells transfected with vector, EFNB2-OE, EFNB2-OE + siLDLR #1, or EFNB2-OE + siLDLR #2 ( n = 6 per group) and animal imaging to monitor tumor growth and PCNA staining by IHC in tumor tissues. Scale bar: 50μm. B Liver injection model created by spleen injection with SW480 luc cells transfected with vector, EFNB2-OE, EFNB2-OE + siLDLR #1, or EFNB2-OE + siLDLR #2 ( n = 6 per group) and animal imaging to monitor tumor growth and PCNA staining by IHC in tumor tissues. Scale bar: 50 μm. C Cholesterol detection in an LM model transfected with vector, EFNB2-OE, EFNB2-OE + siLDLR #1, or EFNB2-OE + siLDLR #2 ( n = 6 per group). D Total cholesterol levels in tumor tissues in an LM model and a liver injection model transfected with vector, EFNB2-OE, EFNB2-OE + siLDLR #1, or EFNB2-OE + siLDLR #2 ( n = 6 per group). E Total cholesterol levels in SW480 CRC cells in FBS-free and cholesterol culture (5 μg/ml Cho), including vector, EFNB2-OE, EFNB2-OE + siLDLR #1, and EFNB2-OE + siLDLR #2 groups. F Total cholesterol levels in HT29 CRC cells in FBS-free and cholesterol culture (5 μg/ml Cho), including vector, EFNB2-OE, EFNB2-OE + siLDLR #1, and EFNB2-OE + siLDLR #2 groups. G The viability of SW620 and LoVo cells in FBS-free culture, including the siNC, siNC + 5 μg/ml Cho, siLDLR #1 + 5 μg/ml Cho, and siLDLR #2 + 5 μg/ml Cho groups, as analyzed using CCK-8 assays. H Viability of SW480 and HT29 cells in FBS-free culture, including vector + 5 μg/ml Cho, EFNB2-OE + 5 μg/ml Cho, EFNB2-OE + NVP-BHG712 + 5 μg/ml Cho, EFNB2-OE + siLDLR #1 + 5 μg/ml Cho, and EFNB2-OE + siLDLR #2 + 5 μg/ml Cho groups, as analyzed using CCK-8 assays. All experiments were performed in triplicate. Measurement data are presented as the mean ± SD. Student’s t -tests were used for statistical analysis. ns. indicates no statistical difference; ** p < 0.01, *** p < 0.001.
Techniques Used: Injection, Transfection, Plasmid Preparation, Imaging, Staining, CCK-8 Assay
Figure Legend Snippet: A Overall survival analysis of patients with CRC LM, based on the protein expression of EFNB2 ( n = 30). B A high cholesterol model was established by providing a high cholesterol diet to BALB/c nude mice. C Total cholesterol levels in the liver tissues of mice with high cholesterol and normal control feeding ( n = 6 per group). D CRC LM models were established using SW620 cells in mice with high cholesterol and normal control feeding, including the sh-NC, sh-EFNB2, and sh-NC + NVP-BHG712 groups ( n = 6 per group). E Overall survival analysis of CRC LM models in mice with high cholesterol and normal control feeding, including the sh-NC, sh-EFNB2, and sh-NC + NVP-BHG712 groups ( n = 6 per group). F Adaptive activation of the EFNB2/EPHB4 axis promoted CRC LM by LDLR-mediated cholesterol uptake. All experiments were performed in triplicate. Measurement data are presented as the mean ± SD. Student’s t -tests were used for statistical analysis. *** p < 0.001.
Techniques Used: Expressing, Control, Activation Assay
Related Articles
other:Article Title: Direct inhibition of cell surface ephrin-B2 by recombinant ephrin-B2/FC. Article Snippet: First messengers and viral transfection are the two most common ways to stimulate cells for signal output, although their applications are limited.. We investigated mechanisms of inducing neural stem cell differentiation using recombinant ephrin-B2/Fc and found that it acted as a ligand and inhibited endogenous ephrin-B2, which maintenance of the neural progenitor cell state, by direct interference.. Our results showed the movement of ephrin-B2/Fc within the cell and indicated that it recycled to the plasma membrane surface, revealing a possible pattern of ephrin trafficking. Article Title: Adaptive activation of EFNB2/EPHB4 axis promotes post-metastatic growth of colorectal cancer liver metastases by LDLR-mediated cholesterol uptake. Article Snippet: All the Article Title: Ephrin B2 (EFNB2) potentially protects against intervertebral disc degeneration through inhibiting nucleus pulposus cell apoptosis. Article Snippet: 11 Nucleus pulposus (NP) cell apoptosis is a significant indication of accelerated 12 intervertebral disc degeneration; however, the precise mechanism is unelucidated as 13 of yet.. Ephrin B2 (EFNB2), the only gene down-regulated in the three degraded 14 intervertebral disc tissue microarray groups (GSE70362, GSE147383 and GSE56081), 15 was screened for examination in this study.. Subsequently, EFNB2 was verified to be 16 down-regulated in degraded NP tissue samples. Article Title: EFNB2 acts as the target of miR-557 to facilitate cell proliferation, migration and invasion in pancreatic ductal adenocarcinoma by bioinformatics analysis and verification Article Snippet: The small interfering RNA of EFNB2 (si-EFNB2), scramble siRNA of EFNB2 (negative control, NC), miR-557 mimics and negative control oligonucleotides (miR-NC) were constructed by GenePharma (Shanghai, China). Article Title: EFNB2 facilitates cell proliferation, migration, and invasion in pancreatic ductal adenocarcinoma via the p53/p21 pathway and EMT. Article Snippet: Small interfering RNA (siRNA) targeting EFNB2 was synthesized and purchased from GenePharma (Shanghai, China). Article Title: Adaptive activation of EFNB2/EPHB4 axis promotes post-metastatic growth of colorectal cancer liver metastases by LDLR-mediated cholesterol uptake Article Snippet: All the Binding Assay:Article Title: MicroRNA-137 Inhibits EFNB2 Expression Affected by a Genetic Variant and Is Expressed Aberrantly in Peripheral Blood of Schizophrenia Patients Article Snippet: RNA folding structures between miRNAs and targeting sequences and the minimum folding energy (MFE) were predicted by RNAhybrid ( http://bibiserv.techfak.uni-bielefeld.de/rnahybrid ) ( , ). .. A 500-bp-long Synthesized:Article Title: MicroRNA-137 Inhibits EFNB2 Expression Affected by a Genetic Variant and Is Expressed Aberrantly in Peripheral Blood of Schizophrenia Patients Article Snippet: RNA folding structures between miRNAs and targeting sequences and the minimum folding energy (MFE) were predicted by RNAhybrid ( http://bibiserv.techfak.uni-bielefeld.de/rnahybrid ) ( , ). .. A 500-bp-long |